- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, October 20, 2017
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A study published in The American Journal of Managed Care® (AJMC®) was cited in a Penn State News article that focused on the opioid epidemic on Wednesday. The study, “State Prescription Drug Monitoring Programs and Fatal Drug Overdoses,” examined the impact of prescription drug monitoring programs (PDMPs) on drug overdose deaths. Results of the study showed that PDMPs were not associated with the reductions in overall drug overdose mortality rate and may be related to increased mortality from illicit drugs and other, unspecified drugs.
The Thursday e-newsletter from National Pharmaceutical Council included 2 articles by AJMC® covering sessions at the Academy of Managed Care Pharmacy (AMCP) 2017 Nexus meeting. The articles covered the growth of outcomes-based risk-sharing contracts and the benefits of these agreements, and the new guidance from FDA regarding healthcare economic information prior to a drug’s approval. For more coverage from AMCP Nexus, which was held October 16-19 in Dallas, Texas, visit the dedicated conference page.
Global Trends in Ovarian Cancer Incidence Highlight Regional, Histological Variations
January 7th 2025Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, influenced by genetic, reproductive, and socioeconomic factors.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Decisions and Precision in Value-Based Cancer Care
January 7th 2025An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for multiple myeloma, and more.
Read More
